You are here:

MS in the Media - 1 May 2020

Published on

On this page

  1. Covid-19 outcomes for people with MS
  2. Smoking and vitamin D affect cognition

25 April - 1 May 2020

These are links to recent news stories about multiple sclerosis that may be of interest to people affected by MS in the UK. The link beneath each item will take you to the original story.

Please note that the MS Trust did not write the original items and does not endorse their content nor any claims made in them.

To keep up to date on all the latest news, views and research on multiple sclerosis, sign up for Open Door, our free newsletter, or regular email alerts.

Covid-19 outcomes for people with MS

People with MS did no worse than the general population according to preliminary results from Italy. Of 232 people with MS affected by the virus, 223 has 'mild' Covid-19 symptoms. In four people the infection was classed as severe and in six as critical. All bar 21 people were taking a disease modifying drug.

Source: The Lancet

MS Trust link: Coronavirus, Covid-19 and multiple sclerosis

Smoking and vitamin D affect cognition

People with clinically isolated syndrome (CIS) who had low vitamin D levels and who smoked were more likely to have worse cognition scores 11 years later, according to a Norwegian study

Source: Medical Xpress

MS Trust link: Smoking

 

Print this page